The US Pentagon has issued detailed, mandatory clinical guidance for testosterone deficiency screening for active-duty and reserve service members aged 30 and older. The policy takes effect immediately and sets standardized screening and treatment pathways for men and women to address hormonal and energy-availability issues and improve readiness.
WHO:US Pentagon
WHAT:Issued mandatory clinical guidelines for testosterone deficiency screening and standardized screening and treatment pathways for eligible service members
WHEN:Sep 2, 2026
WHERE:USA
WHY:To improve military readiness by identifying and managing hormonal and energy-availability issues.
